TARGETED GENETICS CORP /WA/
10-Q, EX-27.1, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TARGETED GENETICS CORP /WA/, 10-Q, 2000-11-14
Next: EMPIRIC ENERGY INC, NT 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      38,831,228
<SECURITIES>                                         0
<RECEIVABLES>                                  638,762
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            39,827,800
<PP&E>                                      12,636,184
<DEPRECIATION>                             (8,131,623)
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                        7,152,510
<BONDS>                                              0
                                0
                                 13,047,172
<COMMON>                                   198,498,165
<OTHER-SE>                               (139,183,147)
<TOTAL-LIABILITY-AND-EQUITY>                72,362,190
<SALES>                                     10,270,308
<TOTAL-REVENUES>                            10,270,308
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            44,258,625
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           (196,422)
<INCOME-PRETAX>                           (35,379,548)
<INCOME-TAX>                              (35,379,548)
<INCOME-CONTINUING>                       (35,379,548)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (35,379,548)
<EPS-BASIC>                                      (.98)
<EPS-DILUTED>                                    (.98)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission